Simplex Trading’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,400
Closed -$34K 10499
2023
Q1
$34K Hold
11,400
﹤0.01% 6382
2022
Q4
$34K Sell
11,400
-13,300
-54% -$39.7K ﹤0.01% 6323
2022
Q3
$73K Buy
24,700
+8,900
+56% +$21.9K ﹤0.01% 5944
2022
Q2
$46K Buy
15,800
+14,800
+1,480% +$45.9K ﹤0.01% 6627
2022
Q1
$3K Sell
1,000
-500
-33% -$2.08K ﹤0.01% 9795
2021
Q4
$6K Buy
1,500
+900
+150% +$3.82K ﹤0.01% 9479
2021
Q3
$3K Hold
600
﹤0.01% 9492
2021
Q2
$3K Buy
600
+518
+632% +$2.71K ﹤0.01% 9679
2021
Q1
$37K Buy
82
+68
+486% +$295 ﹤0.01% 6954
2020
Q4
$5K Buy
14
+10
+250% +$38 ﹤0.01% 7763
2020
Q3
$1K Buy
+4
New +$14 ﹤0.01% 7669
2019
Q4
Sell
-8
Closed -$3K 8468
2019
Q3
$3K Buy
+8
New +$42 ﹤0.01% 6875
2018
Q1
Sell
-500
Closed -$10K 7431
2017
Q4
$10K Buy
+500
New +$5.47K ﹤0.01% 3949

Other funds holding CO

Simplex Trading's CO Position: Q1 2023 in Review

Simplex Trading sold out of Global Cord Blood Corporation (CO) in Q1 2023, closing a stake of 7,338 shares — an estimated $21K sold.

Simplex Trading first reported a position in CO in Q3 2017 and held it in 21 quarters. The position peaked at $124K in Q1 2022. 23 funds tracked by Wall St. Rank hold CO as of Q1 2023.

  • Simplex Trading reported no remaining Global Cord Blood Corporation position as of Q1 2023 after selling out during the quarter.
  • Simplex Trading sold 7,338 Global Cord Blood Corporation shares in Q1 2023, an estimated $21K.
  • Simplex Trading first reported a position in Global Cord Blood Corporation in Q3 2017 and held it in 21 quarters.
  • Simplex Trading's Global Cord Blood Corporation position peaked at $124K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.